Display options
Share it on

West Indian Med J. 2014 Dec;63(7):771-4. doi: 10.7727/wimj.2013.251. Epub 2015 Mar 05.

A Review of Pharmacovigilance.

The West Indian medical journal

J E Campbell, M Gossell-Williams, M G Lee

Affiliations

  1. Pharmacology Section, Department of Basic Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica. [email protected].
  2. Pharmacology Section, Department of Basic Medical Sciences, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica.
  3. Department of Medicine, Faculty of Medical Sciences, The University of the West Indies, Kingston 7, Jamaica.

PMID: 25867582 PMCID: PMC4668980 DOI: 10.7727/wimj.2013.251

Abstract

Pharmacovigilance supports safe and appropriate use of drugs. Spontaneous reporting of adverse drug reactions (ADRs) is an essential component of pharmacovigilance. However, there is significant underreporting of ADRs. Adverse drug reactions have become a major problem in developing countries. Knowledge of pharmacovigilance could form the basis for interventions aimed at improving reporting rates and decreasing ADRs.

References

  1. Circulation. 2010 Feb 23;121(7):948-54 - PubMed
  2. Drug Saf. 2007;30(7):607-9 - PubMed
  3. Am J Health Syst Pharm. 2002 May 1;59(9):841-5 - PubMed
  4. CMAJ. 2005 Mar 15;172(6):765-7 - PubMed
  5. CMAJ. 2006 Jan 17;174(2):191-2 - PubMed
  6. Drug Saf. 2009;32(1):19-31 - PubMed
  7. Drug Saf. 2006;29(5):385-96 - PubMed
  8. Eur J Clin Pharmacol. 2006 Feb;62(2):143-9 - PubMed
  9. JAMA. 1969 Jun 16;208(11):2045-50 - PubMed
  10. BMJ. 1998 Apr 25;316(7140):1295-8 - PubMed
  11. Lancet. 1998 Apr 18;351(9110):1200-1 - PubMed
  12. Expert Rev Clin Pharmacol. 2008 Sep;1(5):695-705 - PubMed
  13. Ann Intern Med. 1950 Dec;33(6):1459-67 - PubMed
  14. Health Aff (Millwood). 2009 Sep-Oct;28(5):w822-31 - PubMed
  15. Eur J Clin Pharmacol. 1998 Aug;54(6):483-8 - PubMed
  16. BMC Clin Pharmacol. 2007;7:8 - PubMed
  17. East Mediterr Health J. 2009 Sep-Oct;15(5):1145-55 - PubMed
  18. Drug Saf. 1998 Jul;19(1):1-10 - PubMed
  19. Pharmacoeconomics. 1999 May;15(5):445-58 - PubMed
  20. BMC Clin Pharmacol. 2009;9:8 - PubMed
  21. JAMA. 1990 Mar 16;263(11):1467-8 - PubMed
  22. Br J Clin Pharmacol. 2007 Feb;63(2):148-56 - PubMed
  23. Eur J Clin Pharmacol. 2005 Jul;61(5-6):479-80 - PubMed
  24. Arch Intern Med. 2005 Jun 27;165(12):1363-9 - PubMed
  25. Ann Intern Med. 1996 Oct 1;125(7):605-13 - PubMed
  26. Drug Saf. 2010 Aug 1;33(8):689-703 - PubMed
  27. N Engl J Med. 2006 Jan 12;354(2):194-201 - PubMed
  28. BMJ. 2004 Jul 3;329(7456):15-9 - PubMed
  29. Ther Clin Risk Manag. 2005 Sep;1(3):181-8 - PubMed
  30. Fam Community Health. 1982 Aug;5(2):58-67 - PubMed
  31. Drug Saf. 1994 Feb;10(2):93-102 - PubMed
  32. J Am Pharm Assoc (Wash). 2001 Mar-Apr;41(2):192-9 - PubMed
  33. N Engl J Med. 2008 Apr 3;358(14):1427-9 - PubMed
  34. JAMA. 1998 Apr 15;279(15):1200-5 - PubMed
  35. J R Soc Med. 1991 Jun;84(6):341-4 - PubMed
  36. Drug Saf. 2003;26(10):721-7 - PubMed
  37. Pharm Pract (Granada). 2008 Oct;6(4):187-90 - PubMed
  38. Pharmacoepidemiol Drug Saf. 2011 Dec;20(12):1295-302 - PubMed
  39. Br J Clin Pharmacol. 2009 Sep;68(3):427-34 - PubMed
  40. Lancet. 2000 Oct 7;356(9237):1255-9 - PubMed
  41. BMJ. 1998 Jul 11;317(7151):119-20 - PubMed
  42. Annu Rev Public Health. 2010;31:419-37 - PubMed

Publication Types